Buprenorphine transdermal system and quality of life in opioid-experienced patients with chronic low back pain

Bibliography

• Dionne CE, Dunn KM, Croft PR, A consensus approach toward the standardization of back pain definitions for use in prevalence studies. Spine (Phila Pa 1976) 2008;33(1):95-103
   PubMed Web of Science ®Google Scholar
• Buchbinder R, Batterham R, Elsworth G, A validity-driven approach to the understanding of the personal and societal burden of low back pain: development of a conceptual and measurement model. Arthritis Res Ther 2011;13(5):R152
   PubMed Web of Science ®Google Scholar
• Ostelo RW, Deyo RA, Stratford P, Interpreting change scores for pain and functional status in low back pain: towards international consensus regarding minimal important change. Spine (Phila Pa 1976) 2008;33(1):90-4
   PubMed Web of Science ®Google Scholar
• Hoy DG, Bain C, Williams G, A systematic review of the global prevalence of low back pain. Arthritis Rheum 2012;64(6):2028-37
   PubMed Web of Science ®Google Scholar
• Strine TW, Hootman JM. US national prevalence and correlates of low back and neck pain among adults. Arthritis Rheum 2007;57(4):656-65
   PubMedGoogle Scholar
• Asche CV, Kirkness CS, McAdam-Marx C, Fritz JM. The societal costs of low back pain: data published between 2001 and 2007. J Pain Palliat Care Pharmacother 2007;21(4):25-33
   PubMedGoogle Scholar
• Druss BG, Marcus SC, Olfson M, Pincus HA. The most expensive medical conditions in America. Health Aff (Millwood) 2002;21(4):105-11
   PubMed Web of Science ®Google Scholar
• Rizzo JA, Abbott TA III, Berger ML. The labor productivity effects of chronic backache in the United States. Med Care 1998;36(10):1471-88
   PubMed Web of Science ®Google Scholar
• Croft PR, Macfarlane GJ, Papageorgiou AC, Outcome of low back pain in general practice: a prospective study. BMJ 1998;316(7141):1356-9
   PubMedGoogle Scholar
• Mersky H, Bogduk N. Classification of chronic pain. 2nd edition. IASP Press; Seattle: 1994
   Google Scholar
• Freburger JK, Holmes GM, Agans RP, The rising prevalence of chronic low back pain. Arch Intern Med 2009;169(3):251-8
   PubMed Web of Science ®Google Scholar
• Ekman M, Jonhagen S, Hunsche E, Jonsson L. Burden of illness of chronic low back pain in Sweden: a cross-sectional, retrospective study in primary care setting. Spine (Phila Pa 1976) 2005;30(15):1777-85
   Google Scholar
• Salaffi F, De Angelis R, Stancati A, Grassi W. Health-related quality of life in multiple musculoskeletal conditions: a cross-sectional population based epidemiological study. II. The MAPPING study. Clin Exp Rheumatol 2005;23(6):829-39
   PubMed Web of Science ®Google Scholar
• Veresciagina K, Ambrozaitis KV, Spakauskas B. Health-related quality-of-life assessment in patients with low back pain using SF-36 questionnaire. Medicina (Kaunas) 2007;43(8):607-13
   Google Scholar
• Kosinski MR, Schein JR, Vallow SM, An observational study of health-related quality of life and pain outcomes in chronic low back pain patients treated with fentanyl transdermal system. Curr Med Res Opin 2005;21(6):849-62
   PubMed Web of Science ®Google Scholar
• Bentsen SB, Wahl AK, Strand LI, Hanestad BR. Relationships between demographic, clinical and pain variables and health-related quality of life in patients with chronic low back pain treated with instrumented fusion. Scand J Caring Sci 2007;21(1):134-43
   Google Scholar
• DeVine J, Norvell DC, Ecker E, Evaluating the correlation and responsiveness of patient reported pain with function and quality of life outcomes after spine surgery. Spine (Phila Pa 1976) 2011;36(21 Suppl):S69-74
   PubMed Web of Science ®Google Scholar
• Rabini A, Aprile I, Padua L, Assessment and correlation between clinical patterns, disability and health-related quality of life in patients with low back pain. Eura Medicophys 2007;43(1):49-54
   Google Scholar
• Ren XS, Selim AJ, Fincke G, Assessment of functional status, low back disability, and use of diagnostic imaging in patients with low back pain and radiating leg pain. J Clin Epidemiol 1999;52(11):1063-71
   Google Scholar
• Veresciagina K, Ambrozaitis KV, Spakauskas B. The measurements of health-related quality-of-life and pain assessment in the preoperative patients with low back pain. Medicina (Kaunas) 2009;45(2):111-22
   Google Scholar
• Allan L, Richarz U, Simpson K, Slappendel R. Transdermal fentanyl versus sustained release oral morphine in strong-opioid naive patients with chronic low back pain. Spine (Phila Pa 1976) 2005;30(22):2484-90
   PubMed Web of Science ®Google Scholar
• Huge V, Schloderer U, Steinberger M, Impact of a functional restoration program on pain and health-related quality of life in patients with chronic low back pain. Pain Med 2006;7(6):501-8
   Google Scholar
• Ruoff GE, Rosenthal N, Jordan D, Tramadol/Acetaminophen combination tablets for the treatment of chronic lower back pain: a multicenter, randomized, double-blind, placebo-controlled outpatient study. Clin Ther 2003;25(4):1123-41
   PubMed Web of Science ®Google Scholar
• Skljarevski V, Zhang S, Desaiah D, Duloxetine versus placebo in patients with chronic low back pain: a 12-week, fixed-dose, randomized, double-blind trial. J Pain 2010;11(12):1282-90
   PubMed Web of Science ®Google Scholar
• Szczurko O, Cooley K, Busse JW, Naturopathic care for chronic low back pain: a randomized trial. PLoS One 2007;2(9):e919
   Google Scholar
• Practice guidelines for chronic pain management. A report by the American Society of Anesthesiologists Task Force on Pain Management, Chronic Pain Section. Anesthesiology 1997;86(4):995-1004
   Google Scholar
• Fourney DR, Andersson G, Arnold PM, Chronic low back pain: a heterogeneous condition with challenges for an evidence-based approach. Spine (Phila Pa 1976) 2011;36(21 Suppl):S1-9
   Google Scholar
• White AP, Arnold PM, Norvell DC, Pharmacologic management of chronic low back pain: synthesis of the evidence. Spine (Phila Pa 1976) 2011;36(21 Suppl):S131-43
   PubMed Web of Science ®Google Scholar
• Martell BA, O'Connor PG, Kerns RD, Systematic review: opioid treatment for chronic back pain: prevalence, efficacy, and association with addiction. Ann Intern Med 2007;146(2):116-27
   PubMed Web of Science ®Google Scholar
• Schofferman J, Mazanec D. Evidence-informed management of chronic low back pain with opioid analgesics. Spine J 2008;8(1):185-94
   Google Scholar
• Przeklasa-Muszynska A, Dobrogowski J. Transdermal buprenorphine for the treatment of moderate to severe chronic pain: results from a large multicenter, non-interventional post-marketing study in Poland. Curr Med Res Opin 2011;27(6):1109-17
   PubMed Web of Science ®Google Scholar
• Muriel C, Failde I, Mico JA, Effectiveness and tolerability of the buprenorphine transdermal system in patients with moderate to severe chronic pain: a multicenter, open-label, uncontrolled, prospective, observational clinical study. Clin Ther 2005;27(4):451-62
   Google Scholar
• Griessinger N, Sittl R, Likar R. Transdermal buprenorphine in clinical practice–a post-marketing surveillance study in 13,179 patients. Curr Med Res Opin 2005;21(8):1147-56
   PubMed Web of Science ®Google Scholar
• Public policy statement on the rights and responsibilities of health care professionals in the use of opioids for the treatment of pain: a consensus document from the American Academy of Pain Medicine, the American Pain Society, and the American Society of Addiction Medicine. Pain Med 2004;5(3):301-2
   Google Scholar
• Dhalla IA, Mamdani MM, Sivilotti ML, Prescribing of opioid analgesics and related mortality before and after the introduction of long-acting oxycodone. CMAJ 2009;181(12):891-6
   PubMed Web of Science ®Google Scholar
• Dunn KM, Saunders KW, Rutter CM, Opioid prescriptions for chronic pain and overdose: a cohort study. Ann Intern Med 2010;152(2):85-92
   PubMed Web of Science ®Google Scholar
• Steiner D, Munera C, Hale M, Efficacy and safety of buprenorphine transdermal system (BTDS) for chronic moderate to severe low back pain: a randomized, double-blind study. J Pain 2011;12(11):1163-73
   PubMed Web of Science ®Google Scholar
• Steiner DJ, Sitar S, Wen W, Efficacy and safety of the seven-day buprenorphine transdermal system in opioid-naive patients with moderate to severe chronic low back pain: an enriched, randomized, double-blind, placebo-controlled study. J Pain Symptom Manage 2011;42(6):903-17
   PubMed Web of Science ®Google Scholar
• Gordon A, Callaghan D, Spink D, Buprenorphine transdermal system in adults with chronic low back pain: a randomized, double-blind, placebo-controlled crossover study, followed by an open-label extension phase. Clin Ther 2010;32(5):844-60
   PubMed Web of Science ®Google Scholar
• Gordon A, Rashiq S, Moulin DE, Buprenorphine transdermal system for opioid therapy in patients with chronic low back pain. Pain Res Manag 2010;15(3):169-78
   PubMed Web of Science ®Google Scholar
• Maruish ME. editor. User's manual for the SF-36v2 health survey. 3rd edition. QualityMetric, Inc; Lincoln, RI: 2011
   Google Scholar
• Kosinski M, Zhao SZ, Dedhiya S, Determining minimally important changes in generic and disease-specific health-related quality of life questionnaires in clinical trials of rheumatoid arthritis. Arthritis Rheum 2000;43(7):1478-87
   PubMed Web of Science ®Google Scholar
• Agresti A, Coull BA. Approximate is better than "Exact" for interval estimation of binomial proportions. Am Stat 1998;52:119-26
   Web of Science ®Google Scholar
• Wallace M, Thipphawong J. Open-label study on the long-term efficacy, safety, and impact on quality of life of OROS hydromorphone ER in patients with chronic low back pain. Pain Med 2010;11(10):1477-88
   PubMedGoogle Scholar
• Yarlas A, Miller K, Wen W, A Randomized, Placebo-Controlled Study of the Impact of the 7-Day Buprenorphine Transdermal System on Health-Related Quality of Life in Opioid-Naive Patients with Moderate-to-Severe Chronic Low Back Pain. J Pain 2012; [Epub ahead of print]
   Google Scholar